Literature DB >> 31038970

In Vitro-in Vivo Correlation of Mucoadhesion Studies on Buccal Mucosa.

Randi Angela Baus1, Michael Franz Haug1, Christina Leichner1, Max Jelkmann1, Andreas Bernkop-Schnürch1.   

Abstract

BACKGROUND: For the development of novel buccoadhesive formulations, their physicochemical properties, strength of the interfacial joint, and residence time on the buccal mucosa are considered as a measure for their in vivo mucoadhesive properties. Focusing on these parameters, the predictive power of established in vitro systems was assessed for mucoadhesive properties in humans using discs as the model solid dosage form.
METHODS: Compressed into discs, hydroxyethyl cellulose, carboxymethyl cellulose, carbopol, polycarbophil, alginate, and xanthan gum were used as model polymers. Mucosal residence time, maximum detachment force (MDF), and total work of adhesion (TWA) were determined ex vivo on the porcine buccal mucosa and in vivo on healthy volunteers. The impact of detachment velocity, humidification, and experimental set-up employed for tensile studies was examined and correlated to in vivo studies.
RESULTS: Ex vivo results for mucosal residence time showed a very high correlation ( r = 0.997) with data obtained in vivo. For tensile studies, a set-up optimized for moistening the interface, speed, and alignment of the tensile force provided ex vivo results with very high correlation to in vivo experiments with r = 0.983 obtained for MDF and r = 0.973 for TWA, respectively.
CONCLUSIONS: Experimental set-ups for the determination of mucosal residence time and tensile studies could be identified as valid methods for the development of intraoral solid dosage forms.

Entities:  

Keywords:  IVIVC; buccoadhesive disc; mucoadhesive polymers; mucosal residence time; tensile studies

Mesh:

Substances:

Year:  2019        PMID: 31038970     DOI: 10.1021/acs.molpharmaceut.9b00254

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  4 in total

1.  Effect of a newly developed pastille on the salivary flow rate in subjects with dry mouth symptoms: a randomized, controlled, monocentric clinical study.

Authors:  S Bielfeldt; D Wilhelm; C Neumeister; U Schwantes; K-P Wilhelm
Journal:  BMC Oral Health       Date:  2021-03-12       Impact factor: 2.757

2.  Development of an Electrospun Patch Platform Technology for the Delivery of Carvedilol in the Oral Mucosa.

Authors:  Maria Pardo-Figuerez; Jorge Teno; Alvaro Lafraya; Cristina Prieto; Jose Maria Lagaron
Journal:  Nanomaterials (Basel)       Date:  2022-01-27       Impact factor: 5.076

3.  Evaluation of Usnea barbata (L.) Weber ex F.H. Wigg Extract in Canola Oil Loaded in Bioadhesive Oral Films for Potential Applications in Oral Cavity Infections and Malignancy.

Authors:  Violeta Popovici; Elena Matei; Georgeta Camelia Cozaru; Laura Bucur; Cerasela Elena Gîrd; Verginica Schröder; Emma Adriana Ozon; Oana Karampelas; Adina Magdalena Musuc; Irina Atkinson; Adriana Rusu; Simona Petrescu; Raul-Augustin Mitran; Mihai Anastasescu; Aureliana Caraiane; Dumitru Lupuliasa; Mariana Aschie; Victoria Badea
Journal:  Antioxidants (Basel)       Date:  2022-08-19

4.  Matrix Tablets Based on Chitosan-Carrageenan Polyelectrolyte Complex: Unique Matrices for Drug Targeting in the Intestine.

Authors:  Alena Komersová; Roman Svoboda; Barbora Skalická; Martin Bartoš; Eva Šnejdrová; Jitka Mužíková; Kevin Matzick
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.